Frontiers in Immunology (Mar 2024)
Heterozygous mutations in factor H aggravate pathological damage in a stable IgA deposition model induced by Lactobacillus casei cell wall extract
- Jingyi Li,
- Jingyi Li,
- Jingyi Li,
- Jingyi Li,
- Jingyi Li,
- Yaping Dong,
- Yaping Dong,
- Yaping Dong,
- Yaping Dong,
- Yaping Dong,
- Feifei Chen,
- Feifei Chen,
- Feifei Chen,
- Feifei Chen,
- Feifei Chen,
- Hongyu Yang,
- Hongyu Yang,
- Hongyu Yang,
- Hongyu Yang,
- Hongyu Yang,
- Pei Chen,
- Pei Chen,
- Pei Chen,
- Pei Chen,
- Pei Chen,
- Hongyu Li,
- Hongyu Li,
- Hongyu Li,
- Hongyu Li,
- Hongyu Li,
- Sufang Shi,
- Sufang Shi,
- Sufang Shi,
- Sufang Shi,
- Sufang Shi,
- Xujie Zhou,
- Xujie Zhou,
- Xujie Zhou,
- Xujie Zhou,
- Xujie Zhou,
- Li Zhu,
- Li Zhu,
- Li Zhu,
- Li Zhu,
- Li Zhu,
- Yuemiao Zhang,
- Yuemiao Zhang,
- Yuemiao Zhang,
- Yuemiao Zhang,
- Yuemiao Zhang,
- Lijun Liu,
- Lijun Liu,
- Lijun Liu,
- Lijun Liu,
- Lijun Liu,
- Xinfang Xie,
- Feng Yu,
- Jing Jin,
- Jicheng Lv,
- Jicheng Lv,
- Jicheng Lv,
- Jicheng Lv,
- Jicheng Lv,
- Hong Zhang,
- Hong Zhang,
- Hong Zhang,
- Hong Zhang,
- Hong Zhang
Affiliations
- Jingyi Li
- Renal Division, Peking University First Hospital, Beijing, China
- Jingyi Li
- Institute of Nephrology, Peking University, Beijing, China
- Jingyi Li
- Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China
- Jingyi Li
- Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China
- Jingyi Li
- State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China
- Yaping Dong
- Renal Division, Peking University First Hospital, Beijing, China
- Yaping Dong
- Institute of Nephrology, Peking University, Beijing, China
- Yaping Dong
- Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China
- Yaping Dong
- Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China
- Yaping Dong
- State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China
- Feifei Chen
- Renal Division, Peking University First Hospital, Beijing, China
- Feifei Chen
- Institute of Nephrology, Peking University, Beijing, China
- Feifei Chen
- Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China
- Feifei Chen
- Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China
- Feifei Chen
- State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China
- Hongyu Yang
- Renal Division, Peking University First Hospital, Beijing, China
- Hongyu Yang
- Institute of Nephrology, Peking University, Beijing, China
- Hongyu Yang
- Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China
- Hongyu Yang
- Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China
- Hongyu Yang
- State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China
- Pei Chen
- Renal Division, Peking University First Hospital, Beijing, China
- Pei Chen
- Institute of Nephrology, Peking University, Beijing, China
- Pei Chen
- Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China
- Pei Chen
- Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China
- Pei Chen
- State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China
- Hongyu Li
- Renal Division, Peking University First Hospital, Beijing, China
- Hongyu Li
- Institute of Nephrology, Peking University, Beijing, China
- Hongyu Li
- Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China
- Hongyu Li
- Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China
- Hongyu Li
- State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China
- Sufang Shi
- Renal Division, Peking University First Hospital, Beijing, China
- Sufang Shi
- Institute of Nephrology, Peking University, Beijing, China
- Sufang Shi
- Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China
- Sufang Shi
- Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China
- Sufang Shi
- State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China
- Xujie Zhou
- Renal Division, Peking University First Hospital, Beijing, China
- Xujie Zhou
- Institute of Nephrology, Peking University, Beijing, China
- Xujie Zhou
- Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China
- Xujie Zhou
- Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China
- Xujie Zhou
- State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China
- Li Zhu
- Renal Division, Peking University First Hospital, Beijing, China
- Li Zhu
- Institute of Nephrology, Peking University, Beijing, China
- Li Zhu
- Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China
- Li Zhu
- Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China
- Li Zhu
- State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China
- Yuemiao Zhang
- Renal Division, Peking University First Hospital, Beijing, China
- Yuemiao Zhang
- Institute of Nephrology, Peking University, Beijing, China
- Yuemiao Zhang
- Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China
- Yuemiao Zhang
- Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China
- Yuemiao Zhang
- State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China
- Lijun Liu
- Renal Division, Peking University First Hospital, Beijing, China
- Lijun Liu
- Institute of Nephrology, Peking University, Beijing, China
- Lijun Liu
- Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China
- Lijun Liu
- Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China
- Lijun Liu
- State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China
- Xinfang Xie
- Department of Nephrology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi'an, China
- Feng Yu
- Department of Nephrology, Peking University International Hospital, Beijing, China
- Jing Jin
- Northwestern University Feinberg School of Medicine, Division of Nephrology, Chicago, IL, United States
- Jicheng Lv
- Renal Division, Peking University First Hospital, Beijing, China
- Jicheng Lv
- Institute of Nephrology, Peking University, Beijing, China
- Jicheng Lv
- Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China
- Jicheng Lv
- Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China
- Jicheng Lv
- State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China
- Hong Zhang
- Renal Division, Peking University First Hospital, Beijing, China
- Hong Zhang
- Institute of Nephrology, Peking University, Beijing, China
- Hong Zhang
- Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China
- Hong Zhang
- Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China
- Hong Zhang
- State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China
- DOI
- https://doi.org/10.3389/fimmu.2024.1368322
- Journal volume & issue
-
Vol. 15
Abstract
IntroductionActivation of complement through the alternative pathway (AP) has a key role in the pathogenesis of IgA nephropathy (IgAN). We previously showed, by intraperitoneal injection of Lactobacillus casei cell wall extract (LCWE), C57BL/6 mice develop mild kidney damage in association with glomerular IgA deposition. To further address complement activity in causing glomerular histological alterations as suggested in the pathogenesis of IgAN, here we used mice with factor H mutation (FHW/R) to render AP overactivation in conjunction with LCWE injection to stimulate intestinal production of IgA.MethodsDose response to LCWE were examined between two groups of FHW/R mice. Wild type (FHW/W) mice stimulated with LCWE were used as model control.ResultsThe FHW/R mice primed with high dose LCWE showed elevated IgA and IgA-IgG complex levels in serum. In addition to 100% positive rate of IgA and C3, they display elevated biomarkers of kidney dysfunction, coincided with severe pathological lesions, resembling those of IgAN. As compared to wild type controls stimulated by the same high dose LCWE, these FHW/R mice exhibited stronger complement activation in the kidney and in circulation.DiscussionThe new mouse model shares many disease features with IgAN. The severity of glomerular lesions and the decline of kidney functions are further aggravated through complement overactivation. The model may be a useful tool for preclinical evaluation of treatment response to complement-inhibitors.
Keywords